Catalyst Wire Dossier Catalyst Wire Dossier

IFOSFAMIDE

IFOSFAMIDE · Fresenius Kabi USA, LLC
Drug timelines are a Plus or Pro feature.

108 regulatory and trial events tracked for IFOSFAMIDE, covering 2007-04-20 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma [Phase 2]

See pricing